Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
HK Stock MarketDetailed Quotes
F8 ENT (08347)
- 0.133
- 0.0000.00%
Market Closed Apr 30 09:00 CST
18.29MMarket Cap26.60P/E (TTM)
0.000High0.000Low0Volume0.133Open0.133Prev Close0.00Turnover0.00%Turnover RatioLossP/E (Static)137.52MShares0.20552wk High0.19P/B18.29MFloat Cap0.09152wk Low--Dividend TTM137.52MShs Float5.447Historical High--Dividend LFY0.00%Range %0.045Historical Low--Avg Price8000Lot Size--Div Yield TTM--Div Yield LFY
F8 ENT (08347) Income Statement
All
YOY
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q9)Dec 31, 2022 | (Q6)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -26.78%134.68M | 19.25%345.79M | 36.26%183.93M | -32.55%289.98M | -45.01%134.98M | -46.86%65.14M | 20.27%429.94M | 34.43%352.08M | 45.46%245.47M | 36.92%122.58M |
| Operating income | -26.78%134.68M | 19.25%345.79M | 36.26%183.93M | -32.55%289.98M | -45.01%134.98M | -46.86%65.14M | 20.27%429.94M | 34.43%352.08M | 45.46%245.47M | 36.92%122.58M |
| Cost of sales | 29.87%-121.99M | -19.12%-328.42M | -36.70%-173.95M | 33.36%-275.71M | 45.72%-127.25M | 47.66%-61.43M | -17.34%-413.7M | -33.30%-335.22M | -45.65%-234.44M | -38.34%-117.36M |
| Operating expenses | 29.87%-121.99M | -19.12%-328.42M | -36.70%-173.95M | 33.36%-275.71M | 45.72%-127.25M | 47.66%-61.43M | -17.34%-413.7M | -33.30%-335.22M | -45.65%-234.44M | -38.34%-117.36M |
| Gross profit | 27.17%12.69M | 21.69%17.37M | 29.03%9.98M | -12.11%14.28M | -29.91%7.73M | -28.96%3.71M | 231.99%16.24M | 61.48%16.86M | 41.48%11.03M | 11.18%5.22M |
| Administrative expenses | 2.06%-7.47M | -4.71%-14.94M | -4.48%-7.62M | 22.37%-14.27M | 13.95%-7.3M | 11.28%-3.43M | -30.69%-18.38M | 1.97%-12.08M | 1.95%-8.48M | 18.24%-3.87M |
| Impairment and provision | ---- | 199.92%2.62M | ---- | 16.26%-2.62M | ---- | ---- | 73.10%-3.13M | ---- | ---- | ---- |
| -Other impairment is provision | ---- | 199.92%2.62M | ---- | 16.26%-2.62M | ---- | ---- | 73.10%-3.13M | ---- | ---- | ---- |
| Special items of operating profit | -494.69%-817K | 8.68%-4.59M | 107.89%207K | -269.81%-5.02M | -201.63%-2.63M | -113.21%-415K | 120.54%2.96M | 113.57%805K | 210.57%2.58M | 154.54%3.14M |
| Operating profit | 72.02%4.4M | 106.09%465K | 216.85%2.56M | -230.66%-7.64M | -142.66%-2.19M | -103.00%-135K | 93.44%-2.31M | 171.44%5.58M | 261.04%5.13M | 273.82%4.5M |
| Financing cost | 71.58%-272K | 25.94%-1.59M | -4.59%-957K | 23.76%-2.15M | 44.88%-915K | 38.79%-486K | 36.53%-2.82M | 35.90%-2.18M | 30.98%-1.66M | -142.07%-794K |
| Share of profits of associates | -331.29%-680K | -87.08%119K | -57.33%294K | -24.32%921K | 114.64%689K | ---- | 273.12%1.22M | 310.81%624K | 528.00%321K | ---- |
| Earning before tax | 81.96%3.45M | 88.65%-1.01M | 178.48%1.9M | -126.74%-8.86M | -163.66%-2.42M | -116.77%-621K | 90.31%-3.91M | 135.03%4.03M | 166.95%3.8M | 323.20%3.7M |
| Tax | ---- | -15.02%181K | ---- | 122.93%213K | ---- | ---- | -185.23%-929K | ---- | ---- | ---- |
| After-tax profit from continuing operations | 81.96%3.45M | 90.46%-825K | 178.48%1.9M | -78.79%-8.65M | -163.66%-2.42M | -116.77%-621K | 87.68%-4.84M | 135.03%4.03M | 166.95%3.8M | 348.85%3.7M |
| Earning after tax | 81.96%3.45M | 90.46%-825K | 178.48%1.9M | -78.79%-8.65M | -163.66%-2.42M | -116.77%-621K | 84.83%-4.84M | 135.54%4.03M | 174.31%3.8M | 118.98%3.7M |
| Shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 135.03%4.03M | ---- | ---- |
| Profit attributable to shareholders | 81.96%3.45M | 90.46%-825K | 178.48%1.9M | -78.79%-8.65M | -163.66%-2.42M | -116.77%-621K | 84.51%-4.84M | 135.29%4.03M | 170.54%3.8M | 192.03%3.7M |
| Basic earnings per share | 81.88%0.0251 | 90.46%-0.006 | 178.41%0.0138 | -58.84%-0.0629 | -149.44%-0.0176 | -112.26%-0.0045 | 87.42%-0.0396 | 129.51%0.0345 | 162.57%0.0356 | 154.86%0.0367 |
| Diluted earnings per share | 81.88%0.0251 | 90.46%-0.006 | 178.41%0.0138 | -58.84%-0.0629 | -149.44%-0.0176 | -112.26%-0.0045 | 87.42%-0.0396 | 129.51%0.0345 | 162.57%0.0356 | 154.86%0.0367 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | -- | National Health Accounting Firm Co., Ltd. | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"